141 related articles for article (PubMed ID: 31195804)
1. Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: An observational cohort study.
Hoffman V; Xue F; Ezzy SM; Yusuf A; Green E; Eisele O; Kurth T; Seeger JD
Cephalalgia; 2019 Oct; 39(12):1544-1559. PubMed ID: 31195804
[TBL] [Abstract][Full Text] [Related]
2. Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
Woolley JM; Bonafede MM; Maiese BA; Lenz RA
Headache; 2017 Oct; 57(9):1399-1408. PubMed ID: 28842990
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis.
Locher C; Kossowsky J; Koechlin H; Lam TL; Barthel J; Berde CB; Gaab J; Schwarzer G; Linde K; Meissner K
JAMA Pediatr; 2020 Apr; 174(4):341-349. PubMed ID: 32040139
[TBL] [Abstract][Full Text] [Related]
4. Topiramate as an adjunctive treatment in migraine prophylaxis.
Martínez HR; Londoño O; Cantú-Martínez L; del Carmen Tarín L; Castillo CD
Headache; 2003; 43(10):1080-4. PubMed ID: 14629243
[TBL] [Abstract][Full Text] [Related]
5. Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
Yaldo AZ; Wertz DA; Rupnow MF; Quimbo RM
Clin Ther; 2008 Dec; 30(12):2452-60. PubMed ID: 19167603
[TBL] [Abstract][Full Text] [Related]
6. Acupuncture for the prevention of episodic migraine.
Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
[TBL] [Abstract][Full Text] [Related]
7. Practical considerations for the treatment of elderly patients with migraine.
Sarchielli P; Mancini ML; Calabresi P
Drugs Aging; 2006; 23(6):461-89. PubMed ID: 16872231
[TBL] [Abstract][Full Text] [Related]
8. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice.
Hall GC; Brown MM; Mo J; MacRae KD
Neurology; 2004 Feb; 62(4):563-8. PubMed ID: 14981171
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant drugs for migraine prophylaxis.
Chronicle E; Mulleners W
Cochrane Database Syst Rev; 2004; (3):CD003226. PubMed ID: 15266476
[TBL] [Abstract][Full Text] [Related]
10. Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects.
Mahmoud AN; Mentias A; Elgendy AY; Qazi A; Barakat AF; Saad M; Mohsen A; Abuzaid A; Mansoor H; Mojadidi MK; Elgendy IY
BMJ Open; 2018 Mar; 8(3):e020498. PubMed ID: 29593023
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic pharmacotherapy for migraine headaches.
Buchanan TM; Ramadan NM
Semin Neurol; 2006 Apr; 26(2):188-98. PubMed ID: 16628529
[TBL] [Abstract][Full Text] [Related]
12. Predicting initiation of preventive migraine medications: exploratory study in a large U.S. medical claims database.
Ford JH; Schroeder K; Buse DC; Joshi S; Gelwicks S; Foster SA; Aurora SK
Curr Med Res Opin; 2020 Jan; 36(1):51-61. PubMed ID: 31422701
[No Abstract] [Full Text] [Related]
13. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.
Zhang M; Solomon DH; Desai RJ; Kang EH; Liu J; Neogi T; Kim SC
Circulation; 2018 Sep; 138(11):1116-1126. PubMed ID: 29899013
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of migraine: a pharmacoepidemiological study].
López Hernández N; Morera Guitart J; Medrano Martínez V; Fernández Izquierdo S; Pérez Sempere A
Neurologia; 2009 Mar; 24(2):98-101. PubMed ID: 19322687
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Treatment of Migraine.
Gürsoy AE; Ertaş M
Noro Psikiyatr Ars; 2013 Aug; 50(Suppl 1):S30-S35. PubMed ID: 28360581
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.
Jackson JL; Cogbill E; Santana-Davila R; Eldredge C; Collier W; Gradall A; Sehgal N; Kuester J
PLoS One; 2015; 10(7):e0130733. PubMed ID: 26172390
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drugs in migraine prevention.
Mathew NT
Headache; 2001; 41 Suppl 1():S18-24. PubMed ID: 11903536
[TBL] [Abstract][Full Text] [Related]
18. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
Adelborg K; Szépligeti SK; Holland-Bill L; Ehrenstein V; Horváth-Puhó E; Henderson VW; Sørensen HT
BMJ; 2018 Jan; 360():k96. PubMed ID: 29386181
[TBL] [Abstract][Full Text] [Related]
19. Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.
Biffi A; Scotti L; Corrao G
Eur J Clin Pharmacol; 2017 Apr; 73(4):487-497. PubMed ID: 28070601
[TBL] [Abstract][Full Text] [Related]
20. [Topiramate in the preventive treatment of migraine: experience in a tertiary center].
Krymchantowski AV; Tavares C; Penteado Jd Jde C; Adriano M
Arq Neuropsiquiatr; 2004 Mar; 62(1):91-5. PubMed ID: 15122440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
